50 studies found for:    NIAID | Open Studies | Exclude Unknown | healthy
Show Display Options
Rank Status Study
21 Recruiting Phase I STEBVax in Healthy Adults
Condition: Toxic Shock Syndrome Staphylococcal
Intervention: Biological: STEBVax
22 Recruiting Aerosolized and Intravenous Colistin in Healthy Adults
Conditions: Pneumonia;   Pneumococcal Infection;   Pathogen Resistance
Interventions: Drug: Colistimethate (Colistin)Sodium-Aerosolized;   Drug: Colistimethate (Colistin)Sodium-Intravenous
23 Not yet recruiting Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects
Condition: Pseudomonas Infection
Interventions: Drug: ZITI-01 (phosphonic acid derivative);   Drug: Monurol®
24 Not yet recruiting Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: SC placebo for VRC01;   Biological: IV placebo for VRC01
25 Not yet recruiting Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123;   Biological: NYVAC-HIV-PT1;   Biological: NYVAC-HIV-PT4;   Biological: AIDSVAX B/E®;   Biological: Placebo vaccine
26 Not yet recruiting Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: DNA Nat-B env vaccine;   Biological: NYVAC Nat-B env vaccine;   Biological: DNA CON-S env vaccine;   Biological: NYVAC CON-S env vaccine;   Biological: DNA Mosaic env vaccine;   Biological: NYVAC Mosaic env vaccine;   Biological: Placebo;   Device: Biojector 2000® Needle-Free Injection Management System™ (Biojector 2000®)
27 Not yet recruiting Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX
28 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Volunteers
Intervention:
29 Recruiting Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies
Condition: Blood Component Removal
Intervention:
30 Recruiting Immune Memory After Papillomavirus Vaccination
Condition: Healthy Volunteers
Intervention: Drug: quadrivalent HPV vaccine
31 Recruiting Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers
Condition: Normal Volunteer
Intervention:
32 Recruiting Analysis of Lyme Disease Lesions
Conditions: Erythema Migrans Lesions;   Erythema Migrans
Intervention:
33 Recruiting Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
Condition: Influenza, Human
Interventions: Biological: A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca);   Biological: A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca);   Biological: 2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®);   Biological: Vaccine placebo (Leibovitz-15 [L-15]);   Biological: Vaccine placebo (FluMist®)
34 Recruiting Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
Condition: Dengue
Interventions: Biological: TetraVax-DV-TV003;   Biological: rDEN2∆30-7169;   Biological: Placebo
35 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
36 Recruiting Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma and in Healthy, Non-asthmatic Control Subjects.
Condition: Asthma
Interventions: Biological: GMP-grade HRV-39;   Procedure: Bronchoalveolar Lavage;   Drug: Methacholine Inhalation Challenge;   Procedure: Nasal Lavage;   Procedure: Nasal Scrapings;   Procedure: Bronchial Brushings;   Procedure: Lung Mucosal Biopsy;   Procedure: Allergen Skin Prick Testing;   Procedure: Venipuncture;   Procedure: Bronchoscopy;   Procedure: Spirometry
37 Recruiting Auranofin PK Following Oral Dose Administration
Condition: Amoebiasis
Intervention: Drug: Auranofin
38 Recruiting Phase I Trial of a Single Dose of CRS3123
Condition: Enteric Infections
Interventions: Other: Placebo;   Drug: CRS3123
39 Recruiting Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.
Condition: Clostridial Infection
Interventions: Drug: Placebo;   Drug: CRS3123
40 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results
Indicates status has not been verified in more than two years